Evidence map›Paper›PMID 38974876›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Omega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia.

Iolanda Lázaro, Oriol Grau-Rivera, Marc Suárez-Calvet, Karine Fauria, Carolina Minguillón, Mahnaz Shekari, Carles Falcón, Marina García-Prat, Jordi Huguet, José Luis Molinuevo and 3 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Iolanda LázaroHospital del Mar Research Institute Barcelona Spain.
Oriol Grau-RiveraHospital del Mar Research Institute Barcelona Spain.
Marc Suárez-CalvetHospital del Mar Research Institute Barcelona Spain.
Karine FauriaBarcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain.
Carolina MinguillónHospital del Mar Research Institute Barcelona Spain.
Mahnaz ShekariHospital del Mar Research Institute Barcelona Spain.
Carles FalcónBarcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain.
Marina García-PratBarcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain.
Jordi HuguetBarcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain.
José Luis MolinuevoBarcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain.
Juan-Domingo GispertHospital del Mar Research Institute Barcelona Spain.ORCID https://orcid.org/0000-0002-6155-0642
Aleix Sala-VilaHospital del Mar Research Institute Barcelona Spain.ORCID https://orcid.org/0000-0002-5038-2794
ALFA study

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBrain glucose hypometabolism is a preclinical feature of Alzheimer's disease (AD). Dietary omega-3 fatty acids promote brain glucose metabolism, but clinical research is incipient. Circulating omega-3s objectively reflect their dietary intake.

methodsThis was a cross-sectional study in 320 cognitively unimpaired participants at increased risk of AD dementia. Using lipidomics, we determined blood docosahexaenoic (DHA) and alpha-linolenic (ALA) acid levels (omega-3s from marine and plant origin, respectively). We assessed brain glucose metabolism using [18-F]-fluorodeoxyglucose (FDG) positron emission tomography (PET).

resultsBlood ALA directly related to FDG uptake in brain areas known to be affected in AD. Stronger associations were observed in apolipoprotein E ε4 carriers and homozygotes. For DHA, significant direct associations were restricted to amyloid beta-positive tau-positive participants. DISCUSSION: Blood omega-3 directly relate to preserved glucose metabolism in AD-vulnerable brain regions in individuals at increased risk of AD dementia. This adds to the benefits of omega-3 supplementation in the preclinical stage of AD dementia. Highlights: Blood omega-3s were related to brain glucose uptake in participants at risk of Alzheimer's disease (AD) dementia.Complementary associations were observed for omega-3 from marine and plant sources.Foods rich in omega-3 might be useful in early features of AD.

Indexed as

biomarkersdietfatty fishfish oiln‐3 fatty acidsnutspolyunsaturated fatty acidswalnuts

Identifiers

PMID38974876
PMCPMC11224768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.